Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
淀粉样变性
淀粉样蛋白（真菌学）
作者
Mathew S. Maurer,Jeffrey H. Schwartz,Balarama Gundapaneni,Perry Elliott,Giampaolo Merlini,Márcia Waddington-Cruz,Arnt V. Kristen,Martha Grogan,Ronald Witteles,Thibaud Damy,Brian Drachman,Sanjiv J. Shah,Mazen Hanna,Daniel P. Judge,Alexandra I. Barsdorf,Peter M. Huber,Terrell A. Patterson,Steven Riley,Jennifer Schumacher,Michelle Stewart,Marla B. Sultan,Claudio Rapezzi
Transthyretin amyloid cardiomyopathy is caused by the deposition of transthyretin amyloid fibrils in the myocardium. The deposition occurs when wild-type or variant transthyretin becomes unstable and misfolds. Tafamidis binds to transthyretin, preventing tetramer dissociation and amyloidogenesis.
Leonardi
不配.
pcr163
薰硝壤
彭于彦祖
shinysparrow
五十一笑声
Henry
Miller
爱静静
顺利的伊
寻道图强
加菲丰丰
竹筏过海
科研文献搬运工
iNk
InfoNinja
陈军
浅尝离白
哎嘿
皖公网安备34019202002308
